Samples from women with BMI ≥ 30 were treated with anti-TNF-α antibody. The relative expression was determined by paired T-Tests between the treated and untreated samples from the same individuals. Significance was accepted when p < 0.05 with a False Discovery Rate cutoff of q ≤ 0.25 applied. 2 Samples from women with BMI < 30 were treated with TNF-α recombinant protein, and the same paired T-tests were used. Significance was accepted when p < 0.05 with a False Discovery Rate cutoff of q ≤ 0.25 applied. 
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